Paper7826293
The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
Arch Ophthalmol, 1995. Cited by 289 papers, by iCite.
Cite this record
ConductScience Library. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Papers, record 7826293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7826293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Diabetic Retinopathy | Major topic |
| Insulin | Major topic |
| Adolescent | |
| Adult | |
| Blood Glucose | |
| Disease Progression | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Incidence | |
| Male | |
| Risk Factors |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00027287 | Laser and Medical Treatment of Diabetic Macular Edema | Background |
Source ClinicalTrials.gov
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40631460 | 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association. | Diabetes Metab J | 2025 | https://conductscience.org/library/papers/40631460 | PubMed |
| 39091005 | 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association. | Diabetes Metab J | 2024 | https://conductscience.org/library/papers/39091005 | PubMed |
| 39063646 | Use of VESsel GENeration with Optical Coherence Tomography Angiography and Fluorescein Angiography for Detection and Quantification of Vascular Changes in Mild and Moderate Diabetic Retinopathy. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39063646 | PubMed |
| 37896220 | Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896220 | PubMed |
| 37781457 | ƩexcessA1C index, the sum of yearly excess HbA1c values during the total period of diabetes, may have the potential to predict retinopathy by a linear regression setting regardless of duration in type 1 diabetes: a subgroup analysis of DCCT/EDIC data. | Diabetol Int | 2023 | https://conductscience.org/library/papers/37781457 | PubMed |
| 36824442 | Diabetic Macular Oedema Guidelines: An Australian Perspective. | J Ophthalmol | 2023 | https://conductscience.org/library/papers/36824442 | PubMed |
| 36815723 | Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/36815723 | PubMed |
| 36482340 | Nomogram model predicts the risk of visual impairment in diabetic retinopathy: a retrospective study. | BMC Ophthalmol | 2022 | https://conductscience.org/library/papers/36482340 | PubMed |
| 35896888 | Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/35896888 | PubMed |
| 35083418 | The effect of select systemic medications on outcomes in diabetics with central retinal vein occlusion. | Ther Adv Ophthalmol | 2022 | https://conductscience.org/library/papers/35083418 | PubMed |
| 35058313 | Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC. | BMJ Open Diabetes Res Care | 2022 | https://conductscience.org/library/papers/35058313 | PubMed |
| 35052620 | Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35052620 | PubMed |
| 34861815 | A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy. | Clin Proteomics | 2021 | https://conductscience.org/library/papers/34861815 | PubMed |
| 34352984 | 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. | Diabetes Metab J | 2021 | https://conductscience.org/library/papers/34352984 | PubMed |
| 34234400 | Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control. | Clin Ophthalmol | 2021 | https://conductscience.org/library/papers/34234400 | PubMed |
| 34233927 | Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. | Diabetes Care | 2021 | https://conductscience.org/library/papers/34233927 | PubMed |
| 34081206 | Decision models in type 2 diabetes mellitus: A systematic review. | Acta Diabetol | 2021 | https://conductscience.org/library/papers/34081206 | PubMed |
| 33928529 | Sexual dysfunctions and short-term glucose variability in young men with type 1 diabetes. | Hormones (Athens) | 2021 | https://conductscience.org/library/papers/33928529 | PubMed |
| 33550441 | Realising the long-term promise of insulin therapy: the DCCT/EDIC study. | Diabetologia | 2021 | https://conductscience.org/library/papers/33550441 | PubMed |
| 33164750 | Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes. | Elife | 2020 | https://conductscience.org/library/papers/33164750 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7826293
GET https://conductscience.org/api/papers/v1/7826293/cited_by?page=2